This review summarizes the electrophysiological mechanisms, electrocardiographic characteristics, clinical presentation, and management of acquired drug-induced long QT syndrome and torsade de pointes.
Since its initial description by Jervell and Lange-Nielsen in 1957, the congenital long QT syndrome (LQTS) has been the most investigated cardiac ion channelopathy. Although congenital LQTS continues to remain the domain of cardiologists, cardiac electrophysiologists, and specialized centers, the by far more frequent acquired drug-induced LQTS is the domain of all physicians and other members of the health care team who are required to make therapeutic decisions. This report will review the electrophysiological mechanisms of LQTS and torsade de pointes, electrocardiographic characteristics of acquired LQTS, its clinical presentation, management, and future directions in the field.
El‐Sherif et al. (Tue,) conducted a review in Acquired long QT syndrome and torsade de pointes. This review summarizes the electrophysiological mechanisms, electrocardiographic characteristics, clinical presentation, and management of acquired drug-induced long QT syndrome and torsade de pointes.